BIOCHEMICAL PHARMACOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2237746, encodeId=5d8f223e746fa, content=11月11日投稿, 12日with editor, 一周过去了, 还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e26491969, createdName=ms8000000177380007, createdTime=Tue Nov 19 10:15:31 CST 2024, time=2024-11-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2234434, encodeId=13d62234434ae, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：5月末投稿，7月中旬一审回来，8月中旬修回，10月初二审回来，10月中旬修回后DIP，已经半个月了还没动静，现在是10月31日，期待六个月内接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Thu Oct 31 22:37:30 CST 2024, time=2024-10-31, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2237539, encodeId=26a1223e539da, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：快三个月了，只有一个审稿人审稿，编辑不再新增审稿人，给编辑发消息催也不回。请问大家这种情况该怎么办，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06561701, createdName=ms5000001769632424, createdTime=Mon Nov 18 09:38:42 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2237780, encodeId=e7f5223e780f2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：请问兄弟姐妹们，有没有只有一个审稿人完成审稿就dip的情况？会接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06561701, createdName=ms5000001769632424, createdTime=Tue Nov 19 13:18:06 CST 2024, time=2024-11-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2191733, encodeId=010b2191e33e4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Thu Mar 07 11:03:01 CST 2024, time=2024-03-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224109, encodeId=4c28222410922, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：3.8投稿，3.14 with editor， 一个多月后under review 后面四月底评审结束 5.8 dip 5.12 reverse 5.20 resubmitted 5.28 with editor 6.3 under review 6.7评审结束 6.11 二返（半月） 后面又经历了催稿对接最后online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:18:38 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237711, encodeId=bc60223e71159, content=该期刊是一本专注于生物化学和药理学领域的国际性学术期刊。它主要发表原创研究、评论和综述文章，涵盖细胞和组织功能的生物化学和分子水平的研究，以及药物的药效学和药代动力学。 投稿前大家要确保文章符合期刊的研究方向和主题，包括但不限于抗感染药物、抗炎药物、心血管药物、内分泌药物、免疫学药物等。 平均审稿周期在1个月左右，录用比例约为50%。在线出版周期平均是9周左右。以上是我了解到期刊内容分享给大家供大家参考了解。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822137, createdTime=Mon Nov 18 23:18:36 CST 2024, time=2024-11-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182826, encodeId=a36c2182826d1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Sat Jan 20 13:28:54 CST 2024, time=2024-01-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2235514, encodeId=03a122355145e, content=偏重的研究方向：药理学;肿瘤;药理 经验分享：请问最近这俩个月的速度怎么样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Wed Nov 06 16:39:52 CST 2024, time=2024-11-06, status=1, ipAttribution=)]

2024-11-19 ms8000000177380007 来自上海

11月11日投稿, 12日with editor, 一周过去了, 还是with editor

12 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237746, encodeId=5d8f223e746fa, content=11月11日投稿, 12日with editor, 一周过去了, 还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e26491969, createdName=ms8000000177380007, createdTime=Tue Nov 19 10:15:31 CST 2024, time=2024-11-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2234434, encodeId=13d62234434ae, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：5月末投稿，7月中旬一审回来，8月中旬修回，10月初二审回来，10月中旬修回后DIP，已经半个月了还没动静，现在是10月31日，期待六个月内接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Thu Oct 31 22:37:30 CST 2024, time=2024-10-31, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2237539, encodeId=26a1223e539da, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：快三个月了，只有一个审稿人审稿，编辑不再新增审稿人，给编辑发消息催也不回。请问大家这种情况该怎么办，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06561701, createdName=ms5000001769632424, createdTime=Mon Nov 18 09:38:42 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2237780, encodeId=e7f5223e780f2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：请问兄弟姐妹们，有没有只有一个审稿人完成审稿就dip的情况？会接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06561701, createdName=ms5000001769632424, createdTime=Tue Nov 19 13:18:06 CST 2024, time=2024-11-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2191733, encodeId=010b2191e33e4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Thu Mar 07 11:03:01 CST 2024, time=2024-03-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224109, encodeId=4c28222410922, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：3.8投稿，3.14 with editor， 一个多月后under review 后面四月底评审结束 5.8 dip 5.12 reverse 5.20 resubmitted 5.28 with editor 6.3 under review 6.7评审结束 6.11 二返（半月） 后面又经历了催稿对接最后online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:18:38 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237711, encodeId=bc60223e71159, content=该期刊是一本专注于生物化学和药理学领域的国际性学术期刊。它主要发表原创研究、评论和综述文章，涵盖细胞和组织功能的生物化学和分子水平的研究，以及药物的药效学和药代动力学。 投稿前大家要确保文章符合期刊的研究方向和主题，包括但不限于抗感染药物、抗炎药物、心血管药物、内分泌药物、免疫学药物等。 平均审稿周期在1个月左右，录用比例约为50%。在线出版周期平均是9周左右。以上是我了解到期刊内容分享给大家供大家参考了解。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822137, createdTime=Mon Nov 18 23:18:36 CST 2024, time=2024-11-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182826, encodeId=a36c2182826d1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Sat Jan 20 13:28:54 CST 2024, time=2024-01-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2235514, encodeId=03a122355145e, content=偏重的研究方向：药理学;肿瘤;药理 经验分享：请问最近这俩个月的速度怎么样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Wed Nov 06 16:39:52 CST 2024, time=2024-11-06, status=1, ipAttribution=)]

2024-10-31 147a5c7fm07(暂无昵称) 来自吉林省

审稿速度:6.0 | 投稿命中率:25.0
经验分享：5月末投稿，7月中旬一审回来，8月中旬修回，10月初二审回来，10月中旬修回后DIP，已经半个月了还没动静，现在是10月31日，期待六个月内接收

20 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237746, encodeId=5d8f223e746fa, content=11月11日投稿, 12日with editor, 一周过去了, 还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e26491969, createdName=ms8000000177380007, createdTime=Tue Nov 19 10:15:31 CST 2024, time=2024-11-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2234434, encodeId=13d62234434ae, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：5月末投稿，7月中旬一审回来，8月中旬修回，10月初二审回来，10月中旬修回后DIP，已经半个月了还没动静，现在是10月31日，期待六个月内接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Thu Oct 31 22:37:30 CST 2024, time=2024-10-31, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2237539, encodeId=26a1223e539da, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：快三个月了，只有一个审稿人审稿，编辑不再新增审稿人，给编辑发消息催也不回。请问大家这种情况该怎么办，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06561701, createdName=ms5000001769632424, createdTime=Mon Nov 18 09:38:42 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2237780, encodeId=e7f5223e780f2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：请问兄弟姐妹们，有没有只有一个审稿人完成审稿就dip的情况？会接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06561701, createdName=ms5000001769632424, createdTime=Tue Nov 19 13:18:06 CST 2024, time=2024-11-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2191733, encodeId=010b2191e33e4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Thu Mar 07 11:03:01 CST 2024, time=2024-03-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224109, encodeId=4c28222410922, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：3.8投稿，3.14 with editor， 一个多月后under review 后面四月底评审结束 5.8 dip 5.12 reverse 5.20 resubmitted 5.28 with editor 6.3 under review 6.7评审结束 6.11 二返（半月） 后面又经历了催稿对接最后online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:18:38 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237711, encodeId=bc60223e71159, content=该期刊是一本专注于生物化学和药理学领域的国际性学术期刊。它主要发表原创研究、评论和综述文章，涵盖细胞和组织功能的生物化学和分子水平的研究，以及药物的药效学和药代动力学。 投稿前大家要确保文章符合期刊的研究方向和主题，包括但不限于抗感染药物、抗炎药物、心血管药物、内分泌药物、免疫学药物等。 平均审稿周期在1个月左右，录用比例约为50%。在线出版周期平均是9周左右。以上是我了解到期刊内容分享给大家供大家参考了解。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822137, createdTime=Mon Nov 18 23:18:36 CST 2024, time=2024-11-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182826, encodeId=a36c2182826d1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Sat Jan 20 13:28:54 CST 2024, time=2024-01-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2235514, encodeId=03a122355145e, content=偏重的研究方向：药理学;肿瘤;药理 经验分享：请问最近这俩个月的速度怎么样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Wed Nov 06 16:39:52 CST 2024, time=2024-11-06, status=1, ipAttribution=)]

2024-11-18 ms5000001769632424 来自山东省

审稿速度:6.0 | 投稿命中率:25.0
经验分享：快三个月了，只有一个审稿人审稿，编辑不再新增审稿人，给编辑发消息催也不回。请问大家这种情况该怎么办，着急毕业

13 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237746, encodeId=5d8f223e746fa, content=11月11日投稿, 12日with editor, 一周过去了, 还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e26491969, createdName=ms8000000177380007, createdTime=Tue Nov 19 10:15:31 CST 2024, time=2024-11-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2234434, encodeId=13d62234434ae, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：5月末投稿，7月中旬一审回来，8月中旬修回，10月初二审回来，10月中旬修回后DIP，已经半个月了还没动静，现在是10月31日，期待六个月内接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Thu Oct 31 22:37:30 CST 2024, time=2024-10-31, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2237539, encodeId=26a1223e539da, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：快三个月了，只有一个审稿人审稿，编辑不再新增审稿人，给编辑发消息催也不回。请问大家这种情况该怎么办，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06561701, createdName=ms5000001769632424, createdTime=Mon Nov 18 09:38:42 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2237780, encodeId=e7f5223e780f2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：请问兄弟姐妹们，有没有只有一个审稿人完成审稿就dip的情况？会接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06561701, createdName=ms5000001769632424, createdTime=Tue Nov 19 13:18:06 CST 2024, time=2024-11-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2191733, encodeId=010b2191e33e4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Thu Mar 07 11:03:01 CST 2024, time=2024-03-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224109, encodeId=4c28222410922, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：3.8投稿，3.14 with editor， 一个多月后under review 后面四月底评审结束 5.8 dip 5.12 reverse 5.20 resubmitted 5.28 with editor 6.3 under review 6.7评审结束 6.11 二返（半月） 后面又经历了催稿对接最后online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:18:38 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237711, encodeId=bc60223e71159, content=该期刊是一本专注于生物化学和药理学领域的国际性学术期刊。它主要发表原创研究、评论和综述文章，涵盖细胞和组织功能的生物化学和分子水平的研究，以及药物的药效学和药代动力学。 投稿前大家要确保文章符合期刊的研究方向和主题，包括但不限于抗感染药物、抗炎药物、心血管药物、内分泌药物、免疫学药物等。 平均审稿周期在1个月左右，录用比例约为50%。在线出版周期平均是9周左右。以上是我了解到期刊内容分享给大家供大家参考了解。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822137, createdTime=Mon Nov 18 23:18:36 CST 2024, time=2024-11-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182826, encodeId=a36c2182826d1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Sat Jan 20 13:28:54 CST 2024, time=2024-01-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2235514, encodeId=03a122355145e, content=偏重的研究方向：药理学;肿瘤;药理 经验分享：请问最近这俩个月的速度怎么样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Wed Nov 06 16:39:52 CST 2024, time=2024-11-06, status=1, ipAttribution=)]

2024-11-19 ms5000001769632424 来自山东省

审稿速度:3.0 | 投稿命中率:25.0
经验分享：请问兄弟姐妹们，有没有只有一个审稿人完成审稿就dip的情况？会接收吗？

12 0

[GetPortalCommentsPageByObjectIdResponse(id=2237746, encodeId=5d8f223e746fa, content=11月11日投稿, 12日with editor, 一周过去了, 还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e26491969, createdName=ms8000000177380007, createdTime=Tue Nov 19 10:15:31 CST 2024, time=2024-11-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2234434, encodeId=13d62234434ae, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：5月末投稿，7月中旬一审回来，8月中旬修回，10月初二审回来，10月中旬修回后DIP，已经半个月了还没动静，现在是10月31日，期待六个月内接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Thu Oct 31 22:37:30 CST 2024, time=2024-10-31, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2237539, encodeId=26a1223e539da, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：快三个月了，只有一个审稿人审稿，编辑不再新增审稿人，给编辑发消息催也不回。请问大家这种情况该怎么办，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06561701, createdName=ms5000001769632424, createdTime=Mon Nov 18 09:38:42 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2237780, encodeId=e7f5223e780f2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：请问兄弟姐妹们，有没有只有一个审稿人完成审稿就dip的情况？会接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06561701, createdName=ms5000001769632424, createdTime=Tue Nov 19 13:18:06 CST 2024, time=2024-11-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2191733, encodeId=010b2191e33e4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Thu Mar 07 11:03:01 CST 2024, time=2024-03-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224109, encodeId=4c28222410922, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：3.8投稿，3.14 with editor， 一个多月后under review 后面四月底评审结束 5.8 dip 5.12 reverse 5.20 resubmitted 5.28 with editor 6.3 under review 6.7评审结束 6.11 二返（半月） 后面又经历了催稿对接最后online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:18:38 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237711, encodeId=bc60223e71159, content=该期刊是一本专注于生物化学和药理学领域的国际性学术期刊。它主要发表原创研究、评论和综述文章，涵盖细胞和组织功能的生物化学和分子水平的研究，以及药物的药效学和药代动力学。 投稿前大家要确保文章符合期刊的研究方向和主题，包括但不限于抗感染药物、抗炎药物、心血管药物、内分泌药物、免疫学药物等。 平均审稿周期在1个月左右，录用比例约为50%。在线出版周期平均是9周左右。以上是我了解到期刊内容分享给大家供大家参考了解。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822137, createdTime=Mon Nov 18 23:18:36 CST 2024, time=2024-11-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182826, encodeId=a36c2182826d1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Sat Jan 20 13:28:54 CST 2024, time=2024-01-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2235514, encodeId=03a122355145e, content=偏重的研究方向：药理学;肿瘤;药理 经验分享：请问最近这俩个月的速度怎么样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Wed Nov 06 16:39:52 CST 2024, time=2024-11-06, status=1, ipAttribution=)]

2024-03-07 ms4000000706495698 来自上海

审稿速度:3.0 | 投稿命中率:50.0
经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。

60 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237746, encodeId=5d8f223e746fa, content=11月11日投稿, 12日with editor, 一周过去了, 还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e26491969, createdName=ms8000000177380007, createdTime=Tue Nov 19 10:15:31 CST 2024, time=2024-11-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2234434, encodeId=13d62234434ae, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：5月末投稿，7月中旬一审回来，8月中旬修回，10月初二审回来，10月中旬修回后DIP，已经半个月了还没动静，现在是10月31日，期待六个月内接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Thu Oct 31 22:37:30 CST 2024, time=2024-10-31, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2237539, encodeId=26a1223e539da, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：快三个月了，只有一个审稿人审稿，编辑不再新增审稿人，给编辑发消息催也不回。请问大家这种情况该怎么办，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06561701, createdName=ms5000001769632424, createdTime=Mon Nov 18 09:38:42 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2237780, encodeId=e7f5223e780f2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：请问兄弟姐妹们，有没有只有一个审稿人完成审稿就dip的情况？会接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06561701, createdName=ms5000001769632424, createdTime=Tue Nov 19 13:18:06 CST 2024, time=2024-11-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2191733, encodeId=010b2191e33e4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Thu Mar 07 11:03:01 CST 2024, time=2024-03-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224109, encodeId=4c28222410922, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：3.8投稿，3.14 with editor， 一个多月后under review 后面四月底评审结束 5.8 dip 5.12 reverse 5.20 resubmitted 5.28 with editor 6.3 under review 6.7评审结束 6.11 二返（半月） 后面又经历了催稿对接最后online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:18:38 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237711, encodeId=bc60223e71159, content=该期刊是一本专注于生物化学和药理学领域的国际性学术期刊。它主要发表原创研究、评论和综述文章，涵盖细胞和组织功能的生物化学和分子水平的研究，以及药物的药效学和药代动力学。 投稿前大家要确保文章符合期刊的研究方向和主题，包括但不限于抗感染药物、抗炎药物、心血管药物、内分泌药物、免疫学药物等。 平均审稿周期在1个月左右，录用比例约为50%。在线出版周期平均是9周左右。以上是我了解到期刊内容分享给大家供大家参考了解。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822137, createdTime=Mon Nov 18 23:18:36 CST 2024, time=2024-11-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182826, encodeId=a36c2182826d1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Sat Jan 20 13:28:54 CST 2024, time=2024-01-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2235514, encodeId=03a122355145e, content=偏重的研究方向：药理学;肿瘤;药理 经验分享：请问最近这俩个月的速度怎么样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Wed Nov 06 16:39:52 CST 2024, time=2024-11-06, status=1, ipAttribution=)]

2024-09-04 ms1000001788820000 来自上海

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：医学
经验分享：3.8投稿，3.14 with editor，
一个多月后under review
后面四月底评审结束
5.8 dip
5.12 reverse
5.20 resubmitted
5.28 with editor
6.3 under review
6.7评审结束
6.11 二返（半月）
后面又经历了催稿对接最后online。

37 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237746, encodeId=5d8f223e746fa, content=11月11日投稿, 12日with editor, 一周过去了, 还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e26491969, createdName=ms8000000177380007, createdTime=Tue Nov 19 10:15:31 CST 2024, time=2024-11-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2234434, encodeId=13d62234434ae, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：5月末投稿，7月中旬一审回来，8月中旬修回，10月初二审回来，10月中旬修回后DIP，已经半个月了还没动静，现在是10月31日，期待六个月内接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Thu Oct 31 22:37:30 CST 2024, time=2024-10-31, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2237539, encodeId=26a1223e539da, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：快三个月了，只有一个审稿人审稿，编辑不再新增审稿人，给编辑发消息催也不回。请问大家这种情况该怎么办，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06561701, createdName=ms5000001769632424, createdTime=Mon Nov 18 09:38:42 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2237780, encodeId=e7f5223e780f2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：请问兄弟姐妹们，有没有只有一个审稿人完成审稿就dip的情况？会接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06561701, createdName=ms5000001769632424, createdTime=Tue Nov 19 13:18:06 CST 2024, time=2024-11-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2191733, encodeId=010b2191e33e4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Thu Mar 07 11:03:01 CST 2024, time=2024-03-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224109, encodeId=4c28222410922, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：3.8投稿，3.14 with editor， 一个多月后under review 后面四月底评审结束 5.8 dip 5.12 reverse 5.20 resubmitted 5.28 with editor 6.3 under review 6.7评审结束 6.11 二返（半月） 后面又经历了催稿对接最后online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:18:38 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237711, encodeId=bc60223e71159, content=该期刊是一本专注于生物化学和药理学领域的国际性学术期刊。它主要发表原创研究、评论和综述文章，涵盖细胞和组织功能的生物化学和分子水平的研究，以及药物的药效学和药代动力学。 投稿前大家要确保文章符合期刊的研究方向和主题，包括但不限于抗感染药物、抗炎药物、心血管药物、内分泌药物、免疫学药物等。 平均审稿周期在1个月左右，录用比例约为50%。在线出版周期平均是9周左右。以上是我了解到期刊内容分享给大家供大家参考了解。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822137, createdTime=Mon Nov 18 23:18:36 CST 2024, time=2024-11-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182826, encodeId=a36c2182826d1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Sat Jan 20 13:28:54 CST 2024, time=2024-01-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2235514, encodeId=03a122355145e, content=偏重的研究方向：药理学;肿瘤;药理 经验分享：请问最近这俩个月的速度怎么样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Wed Nov 06 16:39:52 CST 2024, time=2024-11-06, status=1, ipAttribution=)]

2024-11-18 ms1000001788822137 来自上海

该期刊是一本专注于生物化学和药理学领域的国际性学术期刊。它主要发表原创研究、评论和综述文章，涵盖细胞和组织功能的生物化学和分子水平的研究，以及药物的药效学和药代动力学。
投稿前大家要确保文章符合期刊的研究方向和主题，包括但不限于抗感染药物、抗炎药物、心血管药物、内分泌药物、免疫学药物等。
平均审稿周期在1个月左右，录用比例约为50%。在线出版周期平均是9周左右。以上是我了解到期刊内容分享给大家供大家参考了解。

13 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237746, encodeId=5d8f223e746fa, content=11月11日投稿, 12日with editor, 一周过去了, 还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e26491969, createdName=ms8000000177380007, createdTime=Tue Nov 19 10:15:31 CST 2024, time=2024-11-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2234434, encodeId=13d62234434ae, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：5月末投稿，7月中旬一审回来，8月中旬修回，10月初二审回来，10月中旬修回后DIP，已经半个月了还没动静，现在是10月31日，期待六个月内接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Thu Oct 31 22:37:30 CST 2024, time=2024-10-31, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2237539, encodeId=26a1223e539da, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：快三个月了，只有一个审稿人审稿，编辑不再新增审稿人，给编辑发消息催也不回。请问大家这种情况该怎么办，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06561701, createdName=ms5000001769632424, createdTime=Mon Nov 18 09:38:42 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2237780, encodeId=e7f5223e780f2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：请问兄弟姐妹们，有没有只有一个审稿人完成审稿就dip的情况？会接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06561701, createdName=ms5000001769632424, createdTime=Tue Nov 19 13:18:06 CST 2024, time=2024-11-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2191733, encodeId=010b2191e33e4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Thu Mar 07 11:03:01 CST 2024, time=2024-03-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224109, encodeId=4c28222410922, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：3.8投稿，3.14 with editor， 一个多月后under review 后面四月底评审结束 5.8 dip 5.12 reverse 5.20 resubmitted 5.28 with editor 6.3 under review 6.7评审结束 6.11 二返（半月） 后面又经历了催稿对接最后online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:18:38 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237711, encodeId=bc60223e71159, content=该期刊是一本专注于生物化学和药理学领域的国际性学术期刊。它主要发表原创研究、评论和综述文章，涵盖细胞和组织功能的生物化学和分子水平的研究，以及药物的药效学和药代动力学。 投稿前大家要确保文章符合期刊的研究方向和主题，包括但不限于抗感染药物、抗炎药物、心血管药物、内分泌药物、免疫学药物等。 平均审稿周期在1个月左右，录用比例约为50%。在线出版周期平均是9周左右。以上是我了解到期刊内容分享给大家供大家参考了解。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822137, createdTime=Mon Nov 18 23:18:36 CST 2024, time=2024-11-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182826, encodeId=a36c2182826d1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Sat Jan 20 13:28:54 CST 2024, time=2024-01-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2235514, encodeId=03a122355145e, content=偏重的研究方向：药理学;肿瘤;药理 经验分享：请问最近这俩个月的速度怎么样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Wed Nov 06 16:39:52 CST 2024, time=2024-11-06, status=1, ipAttribution=)]

2024-01-20 ms9000001327347856 来自上海

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：胃癌;肿瘤免疫
经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了

84 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237746, encodeId=5d8f223e746fa, content=11月11日投稿, 12日with editor, 一周过去了, 还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e26491969, createdName=ms8000000177380007, createdTime=Tue Nov 19 10:15:31 CST 2024, time=2024-11-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2234434, encodeId=13d62234434ae, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：5月末投稿，7月中旬一审回来，8月中旬修回，10月初二审回来，10月中旬修回后DIP，已经半个月了还没动静，现在是10月31日，期待六个月内接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Thu Oct 31 22:37:30 CST 2024, time=2024-10-31, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2237539, encodeId=26a1223e539da, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：快三个月了，只有一个审稿人审稿，编辑不再新增审稿人，给编辑发消息催也不回。请问大家这种情况该怎么办，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06561701, createdName=ms5000001769632424, createdTime=Mon Nov 18 09:38:42 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2237780, encodeId=e7f5223e780f2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：请问兄弟姐妹们，有没有只有一个审稿人完成审稿就dip的情况？会接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06561701, createdName=ms5000001769632424, createdTime=Tue Nov 19 13:18:06 CST 2024, time=2024-11-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2191733, encodeId=010b2191e33e4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Thu Mar 07 11:03:01 CST 2024, time=2024-03-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224109, encodeId=4c28222410922, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：3.8投稿，3.14 with editor， 一个多月后under review 后面四月底评审结束 5.8 dip 5.12 reverse 5.20 resubmitted 5.28 with editor 6.3 under review 6.7评审结束 6.11 二返（半月） 后面又经历了催稿对接最后online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:18:38 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237711, encodeId=bc60223e71159, content=该期刊是一本专注于生物化学和药理学领域的国际性学术期刊。它主要发表原创研究、评论和综述文章，涵盖细胞和组织功能的生物化学和分子水平的研究，以及药物的药效学和药代动力学。 投稿前大家要确保文章符合期刊的研究方向和主题，包括但不限于抗感染药物、抗炎药物、心血管药物、内分泌药物、免疫学药物等。 平均审稿周期在1个月左右，录用比例约为50%。在线出版周期平均是9周左右。以上是我了解到期刊内容分享给大家供大家参考了解。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822137, createdTime=Mon Nov 18 23:18:36 CST 2024, time=2024-11-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182826, encodeId=a36c2182826d1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Sat Jan 20 13:28:54 CST 2024, time=2024-01-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2235514, encodeId=03a122355145e, content=偏重的研究方向：药理学;肿瘤;药理 经验分享：请问最近这俩个月的速度怎么样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Wed Nov 06 16:39:52 CST 2024, time=2024-11-06, status=1, ipAttribution=)]

2024-07-11 ms6000000678863567 来自湖北省

2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊

81 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237746, encodeId=5d8f223e746fa, content=11月11日投稿, 12日with editor, 一周过去了, 还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e26491969, createdName=ms8000000177380007, createdTime=Tue Nov 19 10:15:31 CST 2024, time=2024-11-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2234434, encodeId=13d62234434ae, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：5月末投稿，7月中旬一审回来，8月中旬修回，10月初二审回来，10月中旬修回后DIP，已经半个月了还没动静，现在是10月31日，期待六个月内接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Thu Oct 31 22:37:30 CST 2024, time=2024-10-31, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2237539, encodeId=26a1223e539da, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：快三个月了，只有一个审稿人审稿，编辑不再新增审稿人，给编辑发消息催也不回。请问大家这种情况该怎么办，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06561701, createdName=ms5000001769632424, createdTime=Mon Nov 18 09:38:42 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2237780, encodeId=e7f5223e780f2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：请问兄弟姐妹们，有没有只有一个审稿人完成审稿就dip的情况？会接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0d06561701, createdName=ms5000001769632424, createdTime=Tue Nov 19 13:18:06 CST 2024, time=2024-11-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2191733, encodeId=010b2191e33e4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Thu Mar 07 11:03:01 CST 2024, time=2024-03-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224109, encodeId=4c28222410922, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：3.8投稿，3.14 with editor， 一个多月后under review 后面四月底评审结束 5.8 dip 5.12 reverse 5.20 resubmitted 5.28 with editor 6.3 under review 6.7评审结束 6.11 二返（半月） 后面又经历了催稿对接最后online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:18:38 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237711, encodeId=bc60223e71159, content=该期刊是一本专注于生物化学和药理学领域的国际性学术期刊。它主要发表原创研究、评论和综述文章，涵盖细胞和组织功能的生物化学和分子水平的研究，以及药物的药效学和药代动力学。 投稿前大家要确保文章符合期刊的研究方向和主题，包括但不限于抗感染药物、抗炎药物、心血管药物、内分泌药物、免疫学药物等。 平均审稿周期在1个月左右，录用比例约为50%。在线出版周期平均是9周左右。以上是我了解到期刊内容分享给大家供大家参考了解。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822137, createdTime=Mon Nov 18 23:18:36 CST 2024, time=2024-11-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182826, encodeId=a36c2182826d1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Sat Jan 20 13:28:54 CST 2024, time=2024-01-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2235514, encodeId=03a122355145e, content=偏重的研究方向：药理学;肿瘤;药理 经验分享：请问最近这俩个月的速度怎么样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Wed Nov 06 16:39:52 CST 2024, time=2024-11-06, status=1, ipAttribution=)]

2024-11-06 ms6000001668743180

偏重的研究方向：药理学;肿瘤;药理
经验分享：请问最近这俩个月的速度怎么样啊

18 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务